152
Views
10
CrossRef citations to date
0
Altmetric
Review

Copanlisib in the Treatment of Relapsed Follicular Lymphoma: Utility and Experience from the Clinic

& ORCID Icon
Pages 677-692 | Published online: 25 Jan 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Georgios Pongas & Bruce Cheson. (2021) Recent Advances in the Management of Patients with Relapsed/Refractory Follicular Lymphoma. Blood and Lymphatic Cancer: Targets and Therapy 11, pages 55-66.
Read now

Articles from other publishers (9)

Dhanushya Gopal, Rajesh Muthuraj, Rex Devasahayam Arokia Balaya, Saptami Kanekar, Iqrar Ahmed & Jaikanth Chandrasekaran. (2024) Computational discovery of novel FYN kinase inhibitors: a cheminformatics and machine learning-driven approach to targeted cancer and neurodegenerative therapy. Molecular Diversity.
Crossref
Francesc Bosch, John Kuruvilla, Theodoros P. Vassilakopoulos, Danilo Di Maio, Michael C. Wei, Marie-Helene Blanchet Zumofen & Loretta J. Nastoupil. (2024) Indirect Treatment Comparisons of Mosunetuzumab With Third- and Later-Line Treatments for Relapsed/Refractory Follicular Lymphoma. Clinical Lymphoma Myeloma and Leukemia 24:2, pages 105-121.
Crossref
Hamad Ghaleb Dailah, Abdullah Abdu Hommdi, Mahdi Dafer Koriri, Essa Mohammed Algathlan & Syam Mohan. (2024) Potential role of immunotherapy and targeted therapy in the treatment of cancer: A contemporary nursing practice. Heliyon 10:2, pages e24559.
Crossref
Marianna Sirico, Alberto D’Angelo, Caterina Gianni, Chiara Casadei, Filippo Merloni & Ugo De Giorgi. (2023) Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy. Cancers 15:3, pages 703.
Crossref
Qingfang Li, Zhihui Li, Ting Luo & Huashan Shi. (2022) Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy. Molecular Biomedicine 3:1.
Crossref
Mariana Tannoury, Delphine Garnier, Santos A. Susin & Brigitte Bauvois. (2022) Current Status of Novel Agents for the Treatment of B Cell Malignancies: What’s Coming Next?. Cancers 14:24, pages 6026.
Crossref
Hye-Young Min & Ho-Young Lee. (2022) Molecular targeted therapy for anticancer treatment. Experimental & Molecular Medicine 54:10, pages 1670-1694.
Crossref
Kamira Maharaj, Angimar Uriepero, Eva Sahakian & Javier Pinilla-Ibarz. (2022) Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies. Frontiers in Immunology 13.
Crossref
Adrian Minson, Constantine Tam, Michael Dickinson & John F. Seymour. (2022) Targeted Agents in the Treatment of Indolent B-Cell Non-Hodgkin Lymphomas. Cancers 14:5, pages 1276.
Crossref